Table 5 Therapeutic drugs for ocular BS and intestinal BS patients
Overall treatment | Ocular BS (n=135, %) | Intestinal BS (n=174, %) |
|---|---|---|
Glucocorticoid | 116 (85.9) | 167 (96.0) |
Sulfasalazine | 0 (0.0) | 104 (59.8) |
Mesalazine | 0 (0.0) | 15 (8.6) |
Colchicine | 37 (27.4) | 40 (23.0) |
Thalidomide | 128 (94.8) | 150 (86.2) |
Hydroxychloroquine | 12 (8.9) | 17 (9.8) |
Cyclosporine | 98 (72.6) | 147 (84.5) |
Tofacitinib | 27 (20.0) | 6 (3.4) |
Cyclophosphamide | 4 (3.0) | 2 (1.1) |
Methotrexate | 2 (1.5) | 1 (0.6) |
Biologics | 44 (32.6) | 109 (62.6) |